<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xing H</submitter><funding>Consejo Nacional de Investigaciones Científicas y Técnicas</funding><funding>US-Egypt Joint Board on Scientific and Technological Cooperation (U.S. - Egypt Joint Board)</funding><funding>US-Egypt Joint Board on Scientific and Technological Cooperation</funding><funding>National Science Foundation (NSF)</funding><funding>Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)</funding><funding>National Science Foundation</funding><pagination>e2321498121</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11032466</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>121(16)</volume><pubmed_abstract>In recent decades, peptide amphiphiles (PAs) have established themselves as promising self-assembling bioinspired materials in a wide range of medical fields. Herein, we report a dual-therapeutic system constituted by an antimicrobial PA and a cylindrical protease inhibitor (LJC) to achieve broad antimicrobial spectrum and to enhance therapeutic efficacy. We studied two strategies: PA-LJC nanostructures (&lt;i>Encapsulation&lt;/i>) and PA nanostructures + free LJC (&lt;i>Combination&lt;/i>). Computational modeling using a molecular theory for amphiphile self-assembly captures and explains the morphology of PA-LJC nanostructures and the location of encapsulated LJC in agreement with transmission electron microscopy and two-dimensional (2D) NMR observations. The morphology and release profile of PA-LJC </pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Engineering a nanoantibiotic system displaying dual mechanism of action.</pubmed_title><pmcid>PMC11032466</pmcid><funding_grant_id>ANPCyT PICT 1520-2019</funding_grant_id><funding_grant_id>72026321CA00001</funding_grant_id><funding_grant_id>DMR-1941731</funding_grant_id><pubmed_authors>Conda-Sheridan M</pubmed_authors><pubmed_authors>de Campos LJ</pubmed_authors><pubmed_authors>Xing H</pubmed_authors><pubmed_authors>Pereira AJ</pubmed_authors><pubmed_authors>Fiora MM</pubmed_authors><pubmed_authors>Tagliazucchi M</pubmed_authors><pubmed_authors>Aguiar-Alves F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Engineering a nanoantibiotic system displaying dual mechanism of action.</name><description>In recent decades, peptide amphiphiles (PAs) have established themselves as promising self-assembling bioinspired materials in a wide range of medical fields. Herein, we report a dual-therapeutic system constituted by an antimicrobial PA and a cylindrical protease inhibitor (LJC) to achieve broad antimicrobial spectrum and to enhance therapeutic efficacy. We studied two strategies: PA-LJC nanostructures (&lt;i>Encapsulation&lt;/i>) and PA nanostructures + free LJC (&lt;i>Combination&lt;/i>). Computational modeling using a molecular theory for amphiphile self-assembly captures and explains the morphology of PA-LJC nanostructures and the location of encapsulated LJC in agreement with transmission electron microscopy and two-dimensional (2D) NMR observations. The morphology and release profile of PA-LJC </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-04-18T19:43:59.875Z</modification><creation>2025-04-07T07:29:51.483Z</creation></dates><accession>S-EPMC11032466</accession><cross_references><pubmed>38593077</pubmed><doi>10.1073/pnas.2321498121</doi></cross_references></HashMap>